Volume 20, Issue 1, January/February/March 2023
Cover Story
04/13/2023
As a potential recession looms on the heels of the pandemic, it is challenging to predict where the US health care system is headed in 2023. Still, we asked our experts to analyze emerging trends, read the tea leaves, and explain how events...
As a potential recession looms on the heels of the pandemic, it is challenging to predict where the US health care system is headed in 2023. Still, we asked our experts to analyze emerging trends, read the tea leaves, and explain how events...
As a potential recession looms...
04/13/2023
First Report Managed Care
Feature
04/13/2023
In-person mental health services declined by more than 50% after the onset of COVID in March 2020 but were offset by a 16- to 20-fold increase in telehealth services among adults covered by private payers.
In-person mental health services declined by more than 50% after the onset of COVID in March 2020 but were offset by a 16- to 20-fold increase in telehealth services among adults covered by private payers.
In-person mental health services...
04/13/2023
First Report Managed Care
Department
Conference Insider
04/13/2023
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE, discusses her research exploring the risk of COVID-19 infection and complications in pediatric patients with hematologic malignancies and Down syndrome.
Jennifer Wilkes, MD, MSCE,...
04/13/2023
First Report Managed Care
Conference Insider
04/13/2023
Emma Searle, MD, PhD, reviews early data from MajesTEC-2, a trial designed to evaluate the recently approved monoclonal antibody teclistamab in combination with daratumumab and lenalidomide in patients with relapsed/refractory multiple...
Emma Searle, MD, PhD, reviews early data from MajesTEC-2, a trial designed to evaluate the recently approved monoclonal antibody teclistamab in combination with daratumumab and lenalidomide in patients with relapsed/refractory multiple...
Emma Searle, MD, PhD, reviews...
04/13/2023
First Report Managed Care
